Old North State Trust LLC purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 7,326 shares of the company’s stock, valued at approximately $941,000.
Several other institutional investors have also added to or reduced their stakes in the business. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter worth about $25,000. Rakuten Securities Inc. acquired a new stake in Merck KGaA in the 2nd quarter worth approximately $27,000. Solstein Capital LLC acquired a new stake in Merck KGaA in the 2nd quarter worth approximately $33,000. Delos Wealth Advisors LLC purchased a new stake in Merck KGaA during the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC acquired a new position in Merck KGaA during the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Down 3.9%
OTCMKTS MKGAF opened at $158.15 on Friday. The company has a fifty day simple moving average of $163.21 and a two-hundred day simple moving average of $148.95. The stock has a market cap of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
